GlassScriptPhysician profile
Nicole M Sopp
NPI 1548577471
$1,602.97
in general payments reported to CMS, 2019-2025
19 companies · $847 in 2025
The $847 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.00 · 2022: $74.43 · 2023: $376 · 2024: $225 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,448.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $328.28 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $157.31 | 2023-2025 | Cequa |
| Astellas Pharma US INC | $146.88 | 2024-2025 | Izervay |
| Oyster Point Pharma, INC. | $143.87 | 2023-2024 | Tyrvaya |
| Sight Sciences, INC. | $143.12 | 2025 | Tearcare System |
| Alcon Vision LLC | $136.74 | 2022-2023 | Total30, Dailies |
| Genentech USA, INC. | $109.65 | 2023 | Vabysmo |
| Shire North American Group INC | $80.00 | 2019 | |
| Abbvie INC. | $67.11 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $60.50 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $41.54 | 2025 | Catalys System |
| Bausch & Lomb Americas INC. | $39.24 | 2024 | Xiidra, Miebo |
| Rayner Intraocular Lenses Limited | $32.49 | 2025 | Omidria |
| Harrow Eye, LLC | $25.19 | 2025 | Vevye |
| Thea Pharma INC. | $23.14 | 2025 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $19.16 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Horizon Therapeutics Plc | $18.14 | 2023 | Tepezza |
| Eyevance Pharmaceuticals LLC | $17.01 | 2022 | |
| Lkc Technologies, INC. | $13.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Sopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.